Top Stories: Chimera Investment (NYSE:CIM), Synthetic Biologics (NYSEMKT: SYN), SunTrust Banks (NYSE:STI), American Lorain Corporation (NYSEMKT:ALN), Sophiris Bio, Inc. (NASDAQ:SPHS)

On 11 AUG Chimera Investment Corporation (NYSE:CIM) last released its earnings data on Monday. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.09 by $0.01. On average, analysts predict that Chimera Investment Corp. will post $0.39 earnings per share for the current fiscal year. Chimera Investment Corporation (NYSE:CIM) belongs to Financial sector. Its net profit margin is … Continue reading Top Stories: Chimera Investment (NYSE:CIM), Synthetic Biologics (NYSEMKT: SYN), SunTrust Banks (NYSE:STI), American Lorain Corporation (NYSEMKT:ALN), Sophiris Bio, Inc. (NASDAQ:SPHS)

Chris Lewis08/2608/26

Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Recro Pharma, Inc. (NASDAQ:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today announced the appointments of Alfred F. Altomari and Dr. Michael Berelowitz to the Company’s Board of Directors. Recro Pharma Inc (NASDAQ:REPH) stock performance was 1.95% in last session and finished the day at $7.32. Traded volume was 35,553.00million shares in the last session and the average volume of … Continue reading Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Jason Knox04/0104/01